MitoLab is a biotechnology company specializing in cell biology services and product development. Its team works with pioneering research ideas, applying rigorous testing and biotechnology expertise to help advance them through development. The company draws on proprietary technologies, more than 20 years of team experience, advanced research infrastructure, and collaborations with leading universities in Israel and technology partners.

MitoLab’s services cover programmed cell death, mitochondria research, ferroptosis, and oxidative stress models. It also provides in vitro drug screening, work on targeted anti-tumor agents, tumor evolution and drug resistance development, and lentivirus vector services. Additional capabilities include barcoding technology, DNA purification, amplification and sequencing of barcodes, and bioinformatics analysis.

Through partnerships supporting technology pipeline development, including collaborations with Israeli universities and Mitotech and Infoquant in the UK, MitoLab provides specialized research services and helps advance technologies toward the market. The company is based in Rehovot, Israel, and accepts inquiries through its website contact form or by email.